Forum für Wissenschaft, Industrie und Wirtschaft

Hauptsponsoren:     3M 
Datenbankrecherche:

 

Pot-bellied mice mimic obesity

07.12.2001


Genetically engineered mice get fat like we do.


Extra enzyme (right) means more fat round the middle.
© J. Flier



US researchers have genetically engineered mice that realistically mimic the symptoms of human obesity. Studying the mice might explain how the body regulates its fat stores and help find new drugs to treat obesity1.

... mehr zu:
»HSD-1


The mice produce more of a chemical that causes fat to be laid down around the abdomen. Fat tummies, rather than the total quantity of fat, are most closely linked with the health problems of being overweight, such as diabetes, high blood pressure and heart disease.

"This is an important part of our emerging understanding of the common forms of obesity," says Jeff Flier, of Harvard Medical School, Boston. Several pharmaceutical companies are already working on drugs to counteract the chemical’s effects, he adds.

The key chemical is an enzyme called HSD-1. This makes the hormone cortisol in cells.

Researchers had a clue that cortisol was involved in obesity. People with the disease Cushing’s syndrome have too much of the hormone. They build up fat around their abdomens, and suffer the attendant health problems.

But most obese people have normal blood levels of cortisol. Flier and his colleagues reasoned that the control centre might lie inside the cells.

By engineering mice so that their abdominal fat cells produce 2-3 times the normal amount of HSD-1, Flier’s team has pinned down the probable role of the enzyme in human obesity.

"It’s quite a staggering result," says Brian Walker, a hormone researcher at the University of Edinburgh, UK. "None of the other models have so closely mirrored the human condition."

The mice lay down more fat around their middles than their normal counterparts - resulting in a pot belly. They also suffer the health problems associated with obesity.

Hard to stomach

Walker has found that obese people tend to have more HSD-1, and his lab has produced a skinny mouse deficient in the enzyme. He is enthusiastic about HSD-1’s potential as a drug target.

It’s not known whether abdominal fat causes ill health, or is just associated with it. One possibility is that chemicals released by fat, perhaps including cortisol, cause the liver to become less sensitive to insulin, damaging the control of sugar levels in the blood.

We also don’t know if differences in HSD-1 lie behind men’s greater tendency to lay down fat around their stomachs than women. "There are sex differences in rats, but we can’t detect any between men’s and women’s livers," says Walker. "We’re not sure about fat yet."

Flier’s overweight mutant mice also eat more. Why should fat cells release a chemical that makes you fatter, and in the places where fat does most damage? "I don’t have an easy answer," says Flier.

But it may have been advantageous for our ancestors to lay down abdominal fat stores in times of plenty. And abdominal fat is the first to be gained and the first to be lost during lean periods. Avoiding obesity, Flier points out, "is only a recent goal of the human race."

References

  1. Masuzaki, H. et al. A transgenic model of visceral obesity and the metabolic syndrome. Science, 294, 2166 - 2170, (2001).


JOHN WHITFIELD | © Nature News Service

Weitere Berichte zu: HSD-1

Weitere Nachrichten aus der Kategorie Medizin Gesundheit:

nachricht Krankheiten entstehen, wenn das Netzwerk von regulatorischen Autoantikörpern aus der Balance gerät
14.12.2018 | Exzellenzcluster Entzündungsforschung

nachricht Telomerverlängerung entscheidend für Krankheitsverlauf
07.12.2018 | Uniklinik Köln

Alle Nachrichten aus der Kategorie: Medizin Gesundheit >>>

Die aktuellsten Pressemeldungen zum Suchbegriff Innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Data use draining your battery? Tiny device to speed up memory while also saving power

The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.

Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...

Im Focus: Quantenkryptographie ist bereit für das Netz

Wiener Quantenforscher der ÖAW realisierten in Zusammenarbeit mit dem AIT erstmals ein quantenphysikalisch verschlüsseltes Netzwerk zwischen vier aktiven Teilnehmern. Diesen wissenschaftlichen Durchbruch würdigt das Fachjournal „Nature“ nun mit einer Cover-Story.

Alice und Bob bekommen Gesellschaft: Bisher fand quantenkryptographisch verschlüsselte Kommunikation primär zwischen zwei aktiven Teilnehmern, zumeist Alice...

Im Focus: An energy-efficient way to stay warm: Sew high-tech heating patches to your clothes

Personal patches could reduce energy waste in buildings, Rutgers-led study says

What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...

Im Focus: Tödliche Kombination: Medikamenten-Cocktail dreht Krebszellen den Saft ab

Zusammen mit einem Blutdrucksenker hemmt ein häufig verwendetes Diabetes-Medikament gezielt das Krebswachstum – dies haben Forschende am Biozentrum der Universität Basel vor zwei Jahren entdeckt. In einer Folgestudie, die kürzlich in «Cell Reports» veröffentlicht wurde, berichten die Wissenschaftler nun, dass dieser Medikamenten-Cocktail die Energieversorgung von Krebszellen kappt und sie dadurch abtötet.

Das oft verschriebene Diabetes-Medikament Metformin senkt nicht nur den Blutzuckerspiegel, sondern hat auch eine krebshemmende Wirkung. Jedoch ist die gängige...

Im Focus: Lethal combination: Drug cocktail turns off the juice to cancer cells

A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.

The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...

Alle Focus-News des Innovations-reports >>>

Anzeige

Anzeige

VideoLinks
Industrie & Wirtschaft
Veranstaltungen

Pro und Contra in der urologischen Onkologie

14.12.2018 | Veranstaltungen

Konferenz zu Usability und künstlicher Intelligenz an der Universität Mannheim

13.12.2018 | Veranstaltungen

Show Time für digitale Medizin-Innovationen

13.12.2018 | Veranstaltungen

VideoLinks
Wissenschaft & Forschung
Weitere VideoLinks im Überblick >>>
 
Aktuelle Beiträge

Krankheiten entstehen, wenn das Netzwerk von regulatorischen Autoantikörpern aus der Balance gerät

14.12.2018 | Medizin Gesundheit

Pro und Contra in der urologischen Onkologie

14.12.2018 | Veranstaltungsnachrichten

Cohesin treibt die Alterung von Blutstammzellen voran

14.12.2018 | Biowissenschaften Chemie

Weitere B2B-VideoLinks
IHR
JOB & KARRIERE
SERVICE
im innovations-report
in Kooperation mit academics